Cytomegalovirus-induced T cell responses accelerate Alzheimer's disease progression in mice.
Overview
- Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK
- Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff CF14 4XW, UK
- Dementia Research Institute, Cardiff University, Cardiff CF24 4HQ, UK
- European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Cardiff CF24 4HQ, UK
Abstract
Infections have long been implicated as causative factors in Alzheimer’s disease (AD). Multiple studies have further suggested a key role for herpesviruses, such as cytomegalovirus (CMV).
Using transgenic 3xTg-AD mice, we demonstrate that systemic infection with the β-herpesvirus murine CMV (MCMV) accelerates the development of cognitive decline, tauopathy and synaptic loss in the hippocampus, all of which are key features of AD.
Accelerated disease progression after infection was associated with substantial lymphocyte infiltration into the brain, dominated by MCMV-specific effector memory CD8+ T cells expressing CXCR3. T cell receptor analyses revealed that clonally diverse virus-specific CD8+ T cells were selectively recruited into the brain during the development of AD. T cell depletion or treatment with the antiviral drug valganciclovir during chronic infection reduced lymphocytic infiltrates in the brain and reversed cognitive decline.
These data provide a mechanistic link between chronic viral infections and the development of AD.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- zenodo:15125167, at Zenodo; found in “Data availability”
Data availability
All original TCR sequencing data are freely available in fully annotated form via Zenodo (10.5281/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 17 authors, 6 keywords, 12 MeSH terms, 5 funders, 65 references.
Cite
This paper
Marsden, M., McLaren, J. E., Bevan, R. J., Penn-Ripley, D., Somerville, M., Lauder, S. N., Jones, M. H., Maros, L.-B., McGurk, M. R., Gallimore, A., Price, D. A., Miners, K. L., Ladell, K., Siebzehnrubl, F. A., Hughes, T. R., Humphreys, I. R., & Clement, M. (2026). Cytomegalovirus-induced T cell responses accelerate Alzheimer's disease progression in mice. Brain : a journal of neurology, 149(9), 3214-3227. https://
BibTeX
@article{marsden2026cyto
author = {Marsden, Morgan and McLaren, James E and Bevan, Ryan J and Penn-Ripley, Daisy and Somerville, Michelle and Lauder, Sarah N and Jones, Manon H and Maros, Lila-Blythe and McGurk, Matthew R and Gallimore, Awen and Price, David A and Miners, Kelly L and Ladell, Kristin and Siebzehnrubl, Florian A and Hughes, Timothy R and Humphreys, Ian R and Clement, Mathew},
title = {{Cytomegalovirus-induce
journal = {Brain : a journal of neurology},
year = {2026},
month = sep,
volume = {149},
number = {9},
pages = {3214--3227},
publisher = {Oxford University Press},
issn = {0006-8950},
doi = {10.1093/
url = {https://
pmid = {42442404},
pmcid = {PMC13548865}
}
RIS
TY - JOUR
AU - Marsden, Morgan
AU - McLaren, James E
AU - Bevan, Ryan J
AU - Penn-Ripley, Daisy
AU - Somerville, Michelle
AU - Lauder, Sarah N
AU - Jones, Manon H
AU - Maros, Lila-Blythe
AU - McGurk, Matthew R
AU - Gallimore, Awen
AU - Price, David A
AU - Miners, Kelly L
AU - Ladell, Kristin
AU - Siebzehnrubl, Florian A
AU - Hughes, Timothy R
AU - Humphreys, Ian R
AU - Clement, Mathew
TI - Cytomegalovirus-induced T cell responses accelerate Alzheimer's disease progression in mice
T2 - Brain : a journal of neurology
J2 - Brain
PY - 2026
DA - 2026/
VL - 149
IS - 9
SP - 3214
EP - 3227
SN - 0006-8950
PB - Oxford University Press
DO - 10.1093/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1093/
"type": "article-journal",
"title": "Cytomegalovirus-induced
"container-title": "Brain : a journal of neurology",
"author": [
{
"family": "Marsden",
"given": "Morgan"
},
{
"family": "McLaren",
"given": "James E"
},
{
"family": "Bevan",
"given": "Ryan J"
},
{
"family": "Penn-Ripley",
"given": "Daisy"
},
{
"family": "Somerville",
"given": "Michelle"
},
{
"family": "Lauder",
"given": "Sarah N"
},
{
"family": "Jones",
"given": "Manon H"
},
{
"family": "Maros",
"given": "Lila-Blythe"
},
{
"family": "McGurk",
"given": "Matthew R"
},
{
"family": "Gallimore",
"given": "Awen"
},
{
"family": "Price",
"given": "David A"
},
{
"family": "Miners",
"given": "Kelly L"
},
{
"family": "Ladell",
"given": "Kristin"
},
{
"family": "Siebzehnrubl",
"given": "Florian A"
},
{
"family": "Hughes",
"given": "Timothy R"
},
{
"family": "Humphreys",
"given": "Ian R"
},
{
"family": "Clement",
"given": "Mathew"
}
],
"container-title-short":
"volume": "149",
"issue": "9",
"page": "3214-3227",
"DOI": "10.1093/
"PMID": "42442404",
"PMCID": "PMC13548865",
"ISSN": "0006-8950",
"publisher": "Oxford University Press",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
9,
1
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1126/sciadv.adz1686
- Persistent microglial activation following neonatal CMV infection mediates neurodegeneration.Journal: Science advancesIn common: other condition, mouse, 7 references
- [2] doi:10.1093/braincomms/fcaf438 [code]
- &
lt;i& gt;HLA's& lt;/ i& gt; hidden hand in Alzheimer's disease-five research questions en route to an answer. Journal: Brain communicationsIn common: Alzheimer's / dementia, cellular / molecular, 8 references - [3] doi:10.1186/s13073-023-01155-w
- The neuroimmune axis of Alzheimer's disease.Journal: Genome medicineIn common: Alzheimer's / dementia, cellular / molecular, 6 references
- [4] doi:10.3389/fimmu.2023.1154699
- T cell aging and Alzheimer's disease.Journal: Frontiers in immunologyIn common: Alzheimer's / dementia, cellular / molecular, 5 references
- [5] doi:10.1186/s40478-022-01404-w
- Terminal complement pathway activation drives synaptic loss in Alzheimer's disease models.Journal: Acta neuropathologica communicationsIn common: Alzheimer's / dementia, mouse, cellular / molecular, 1 reference, author Ryan J Bevan
- [6] doi:10.1038/s41467-025-62405-6
- CD103&
lt;sup& gt;-& lt;/ sup& gt;CD8& lt;sup& gt;+& lt;/ sup& gt; T cells promote neurotoxic inflammation in Alzheimer's disease via granzyme K-PAR-1 signaling. Journal: Nature communicationsIn common: Alzheimer's / dementia, mouse, cellular / molecular, 5 references - [7] doi:10.1038/s44400-026-00066-y [code]
- A high-throughput, quantitative platform using 2D dissociated human cerebral organoids to model neuroinflammation in Alzheimer's disease.Journal: NPJ dementiaIn common: Alzheimer's / dementia, cellular / molecular, 4 references
- [8] doi:10.7554/elife.83451
- TPL2 kinase activity regulates microglial inflammatory responses and promotes neurodegeneration in tauopathy mice.Journal: eLifeIn common: Alzheimer's / dementia, other condition, mouse, 1 other category, 4 references
- [9] doi:10.1073/pnas.2401420121
- Antigen-specific age-related memory CD8 T cells induce and track Alzheimer's-like neurodegeneration.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: Alzheimer's / dementia, other condition, mouse, 4 references
- [10] doi:10.1186/s12974-024-03255-9
- Myeloid gasdermin D drives early-stage T cell immunity and peripheral inflammation in a mouse model of Alzheimer's disease.Journal: Journal of neuroinflammationIn common: Alzheimer's / dementia, mouse, cellular / molecular, 4 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
